510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
QSQClass II

Transcutaneous Electrical Nerve Stimulator To Treat Fibromyalgia Symptoms

21 CFR 882.5888 / Neurology
FDA source (opens on fda.gov)

QSQ is the FDA product code for Transcutaneous Electrical Nerve Stimulator To Treat Fibromyalgia Symptoms, a class II device type, regulated under 21 CFR 882.5888. FDA's definition for this code reads: "Transcutaneous electrical nerve stimulator to treat fibromyalgia symptoms". As of , FDA records hold one 510(k) clearance under this code, the most recent dated , and no recalls.

Classification record

Product code
QSQ
Device name
Transcutaneous Electrical Nerve Stimulator To Treat Fibromyalgia Symptoms
FDA definition
Transcutaneous electrical nerve stimulator to treat fibromyalgia symptoms.
Regulation
21 CFR 882.5888
Device class
Class II
Review panel
Neurology
Submission type
510(k)
Implant
No
Life sustaining or supporting
No
GMP exempt
No
Third party review eligible
No
Ingested clearances
1
Ingested recalls
0

Clearances, product code QSQ

By decision year
1 clearance under product code QSQ with a decision year between 2022 and 2022, 2022 the highest year at 1.
Show the numbers
510(k) clearances under FDA product code QSQ by decision year
YearClearances
20221

Applicants with the most clearances

Product code QSQ
Applicants holding the most 510(k) clearances under product code QSQ
ApplicantClearances
Neurometrix, Inc.1

Companies listing this code with FDA

Companies whose registered establishments list this code